Establishing the GWAS Catalog as a resource for large-scale association studies
Establishing the GWAS Catalog as a resource for large-scale association studies
批准号:
10165278
负责人:
Fiona Cunningham
金额:
$16.88万
依托单位国家:
美国
项目类别:
财政年份:
2014
资助国家:
美国
项目状态:
已结题
起止时间:
2014-09-01 至 2022-06-30
关键词:
AddressAgeArchivesAuthorization documentationCOVID-19COVID-19 pandemicCatalogsCessation of lifeClinicalClinical DataCodeCohort StudiesCollaborationsCollectionCommunitiesCoupledDataData AnalysesData ScienceData SetDevelopmentDiseaseDrug TargetingEnsureEnvironmentEthicsEuropeanFast Healthcare Interoperability ResourcesFinlandGenderGeneticGenetic studyGenomeGenotypeHealthHealthcareHospitalizationHospitalsHumanIndividualIndustrializationInfectionInformaticsInfrastructureIntegration Host FactorsInternationalInterventionInvestmentsLength of StayLife StyleLongitudinal cohort studyMapsMeasuresMediatingMetadataMethodsModelingNational Human Genome Research InstituteOntologyParkinson DiseaseParticipantPatientsPharmacologic SubstancePhenotypePoliciesProcessResearchResearch PersonnelResourcesRisk FactorsRoleSchemeSecureSemanticsSeverity of illnessSourceSpainStandardizationStreamSurveysSwedenSymptomsSystemTimeTwin StudiesVisualizationbasebiobankburden of illnesscohortcomorbiditycoronavirus diseasedata accessdata dictionarydata integrationdata sharingdemographicsdesigndisease heterogeneitydistributed datagenetic associationgenome wide association studygenomic datahuman dataimprovednovelpersonalized medicinephenomephenotypic datapublic health interventionsharing platform
中文摘要
点击翻译按钮获取中文摘要
英文摘要
PROJECT SUMMARY: Accelerating access and sharing of COVID-19 human host genetic and phenotype data
Early evidence from twin studies suggests that approximately 50% of COVID-19 disease burden is
determined by host genetics. The identification of host factors for COVID-19 will directly influence the
development of public health intervention strategies and the identification of drug targets. There are a variety
of existing cohort longitudinal studies with existing genetic and clinical data, e.g. UK Biobank, AllofUs,
23andMe, Ancestry.com who are engaging existing cohort participants for information on COVID-19 disease
burden. The COVID-19 Host Genetics Initiative (COVID-19-HGI) is an international consortium that aims to
identify host genetic associations of COVID-19 by combining data from human cohorts. The European
Genome-phenome Archive (EGA) and the NHGRI Analysis, Visualization, and Informatics Lab-space
AnVIL/Terra platforms are founding partners that form the data sharing and analysis platform. The EGA is a
GA4GH driver project and can rapidly acquire these data enabling ethical genomic data sharing. This extends
the international data sharing infrastructure and processes enabling access to human controlled access data
relevant to addressing the COVID-19 pandemic.
Aim 1: Host submissions to the COVID-19-HGI data sharing platform
The EGA has previously received submissions from over 144 US submitters and US based users represent
33% of the total user community which streams 8.6 PB of data last year. The COVID-19 pandemic is expected
to significantly increase this number through planned new industrial collaboration (e.g. Ancestry.com,
Regeneron Pharmaceuticals). There is an opportunity to develop new submission templates and processes
to enable more rapid submission of genetic and phenotype data.
Aim 2: COVID-19 host metadata harmonisation
Recording and collection of clinical patient data of COVID-19 disease burden is a critical requirement.
Phenotype information is collected using a variety of formats, coding schemes, surveys, and ontologies.
Using the COVID-19-HGI data dictionary, we will construct a common minimal metadata model that will map
across COVID-19 studies for genetic association studies.
Aim 3: Rapid integrated data access and flow into COVID-19-HGI analysis platform
Rapid integration of new human genotypes and phenotyping will be essential to determine reliable and well
supported genetic associations. The NHGRI AnVIL and Terra platform will be the analysis platform for the
COVID-19-HGI. We will use GA4GH standards to provide rapid data access and integration of US COVID-
19 data. This will result in more rapid and seamless human data flow between EGA and AnVIL to provide
additional power to COVID-19 host association studies
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Strengthening community knowledge bases for genetic association studies and polygenic scores, the GWAS and PGS Catalogs
-
批准号:10494308
-
项目类别:
-
资助金额:$119.01万
-
财政年份:2022
-
负责人:Fiona Cunningham
-
依托单位:
Establishing the GWAS Catalog as a resource for large-scale association studies
-
批准号:10218233
-
项目类别:
-
资助金额:$81.86万
-
财政年份:2014
-
负责人:Fiona Cunningham
-
依托单位:
Establishing the GWAS Catalog as a resource for large-scale association studies
-
批准号:9356607
-
项目类别:
-
资助金额:$81.86万
-
财政年份:2014
-
负责人:Fiona Cunningham
-
依托单位:
国内基金
海外基金
登录
查看更多内容
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
-
批准号:JCZRLH202601523
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
-
批准号:JCZRQN202500010
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:
-
依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
-
批准号:2025JJ70209
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:雷芬芳
-
依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
-
批准号:--
-
项目类别:面上项目
-
资助金额:--
-
批准年份:2024
-
负责人:万荣
-
依托单位:
甜茶抑制AGE-RAGE通路增强突触可塑性改善小鼠抑郁样行为
-
批准号:2023JJ50274
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2023
-
负责人:贺志明
-
依托单位:
蒙药额尔敦-乌日勒基础方调控AGE-RAGE信号通路改善术后认知功能障碍研究
-
批准号:--
-
项目类别:地区科学基金项目
-
资助金额:33万元
-
批准年份:2022
-
负责人:都义日
-
依托单位:
补肾健脾祛瘀方调控AGE/RAGE信号通路在再生障碍性贫血骨髓间充质干细胞功能受损的作用与机制研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:52万元
-
批准年份:2022
-
负责人:叶宝东
-
依托单位:
LncRNA GAS5在2型糖尿病动脉粥样硬化中对AGE-RAGE 信号通路上相关基因的调控作用及机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2022
-
负责人:于海兵
-
依托单位:
围绕GLP1-Arginine-AGE/RAGE轴构建探针组学方法探索大柴胡汤异病同治的效应机制
-
批准号:81973577
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2019
-
负责人:辛贵忠
-
依托单位:
AGE/RAGE通路microRNA编码基因多态性与2型糖尿病并发冠心病的关联研究
-
批准号:81602908
-
项目类别:青年科学基金项目
-
资助金额:18.0万元
-
批准年份:2016
-
负责人:刘括
-
依托单位: